Imetabolic Biopharma Corporation
UEI: YB81A2HDHT65
• CAGE: 81TS4
Overview
Awardee Type
Parent
Company Description
Early stage precision medicine biopharma company focusing on obesity related disease, with specific emphasis on cardiovascular disease.
Name
Imetabolic Biopharma Corporation
Website
Headquarters
Phoenix, AZ
United States
United States
Most Recent Award
Sept. 15, 2024
Calculating
Federal grant recipient
IMETABOLIC BIOPHARMA CORPORATION
(UEI YB81A2HDHT65, CAGE 81TS4)
is headquartered in Phoenix AZ.
The corporation
was founded in November 2017 and
federally registered in
February 2018.
Federal Award Analysis
Imetabolic Biopharma Corporation federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
IMETABOLIC BIOPHARMA CORPORATION
UEI
YB81A2HDHT65
CAGE Code
81TS4
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
Asian-Pacific American Owned
Minority Owned Business
Minority Owned Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
Nov. 17, 2017
Initial Registration
Feb. 12, 2018
Last Registration
April 6, 2026
Registration Activation
April 2, 2026
Registration Expiration
March 23, 2027
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
State of Incorporation
NV
Country of Incorporation
USA
Employees
Not Available
Reported NAICS
None Reported
Accepts Credit Cards
No